Effectiveness of Chronic Obstructive Pulmonary Disease-Management Programs: Systematic Review and Meta-Analysis
Abstract Background Disease-management programs may enhance the quality of care provided to patients with chronic diseases, such as chronic obstructive pulmonary disease (COPD). The aim of this systematic review was to assess the effectiveness of COPD disease-management programs. Methods We conducte...
Gespeichert in:
Veröffentlicht in: | The American journal of medicine 2008-05, Vol.121 (5), p.433-443.e4 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 443.e4 |
---|---|
container_issue | 5 |
container_start_page | 433 |
container_title | The American journal of medicine |
container_volume | 121 |
creator | Peytremann-Bridevaux, Isabelle, MD, MPH, DSc Staeger, Philippe, MD, MPH Bridevaux, Pierre-Olivier, MD, MSc Ghali, William A., MD, MPH Burnand, Bernard, MD, MPH |
description | Abstract Background Disease-management programs may enhance the quality of care provided to patients with chronic diseases, such as chronic obstructive pulmonary disease (COPD). The aim of this systematic review was to assess the effectiveness of COPD disease-management programs. Methods We conducted a computerized search of MEDLINE, EMBASE, CINAHL, PsychINFO, and the Cochrane Library (CENTRAL) for studies evaluating interventions meeting our operational definition of disease management: patient education, 2 or more different intervention components, 2 or more health care professionals actively involved in patients' care, and intervention lasting 12 months or more. Programs conducted in hospital only and those targeting patients receiving palliative care were excluded. Two reviewers evaluated 12,749 titles and fully reviewed 139 articles; among these, data from 13 studies were included and extracted. Clinical outcomes considered were all-cause mortality, lung function, exercise capacity (walking distance), health-related quality of life, symptoms, COPD exacerbations, and health care use. A meta-analysis of exercise capacity and all-cause mortality was performed using random-effects models. Results The studies included were 9 randomized controlled trials, 1 controlled trial, and 3 uncontrolled before–after trials. Results indicate that the disease-management programs studied significantly improved exercise capacity (32.2 m, 95% confidence interval [CI], 4.1-60.3), decreased risk of hospitalization, and moderately improved health-related quality of life. All-cause mortality did not differ between groups (pooled odds ratio 0.84, 95% CI, 0.54-1.40). Conclusion COPD disease-management programs modestly improved exercise capacity, health-related quality of life, and hospital admissions, but not all-cause mortality. Future studies should explore the specific elements or characteristics of these programs that bring the greatest benefit. |
doi_str_mv | 10.1016/j.amjmed.2008.02.009 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_69168443</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S0002934308001770</els_id><sourcerecordid>1507559891</sourcerecordid><originalsourceid>FETCH-LOGICAL-c472t-20f395d909117e76ef8827573c5b40256c93754909d3e14d6999e0dd9dae0a6d3</originalsourceid><addsrcrecordid>eNqFkltv1DAQhSMEokvhHyAUIcFblvEtiXlAqpZykVq1ovBsee1JccileJKi_fc47Gof-oL8YFnzndH4nMmylwzWDFj5rl3bvu3RrzlAvQa-BtCPshVTShUVK_njbAUAvNBCipPsGVGbnqBV-TQ7YbVUJUhYZeN506Cbwj0OSJSPTb75GcchuPxqS1Oc_5Xy67nrx8HGXf4xEFrC4tIO9hZ7HKb8Oo630fb0Pr_Z0YS9nZL6G94H_JPbweeXONnibLDdjgI9z540tiN8cbhPsx-fzr9vvhQXV5-_bs4uCicrPhUcGqGV16AZq7AqsalrXqlKOLWVwFXptKiUTHUvkElfaq0RvNfeItjSi9Ps7b7vXRx_z0iT6QM57Do74DiTKTUraylFAl8_ANtxjmlaMlyko7SoEyT3kIsjUcTG3MXQJz8MA7OkYVqzT8MsaRjgJlmdZK8OveftUjuKDvYn4M0BsORs10Q7uEBHjoNaRpCJ-7DnMFmWjI2GXMDBoQ8xpWf8GP43ycMGrgspZdv9wh3S8cvMUBKYm2VzlsWBGoBVFYi_rQq-Yw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>232325938</pqid></control><display><type>article</type><title>Effectiveness of Chronic Obstructive Pulmonary Disease-Management Programs: Systematic Review and Meta-Analysis</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Peytremann-Bridevaux, Isabelle, MD, MPH, DSc ; Staeger, Philippe, MD, MPH ; Bridevaux, Pierre-Olivier, MD, MSc ; Ghali, William A., MD, MPH ; Burnand, Bernard, MD, MPH</creator><creatorcontrib>Peytremann-Bridevaux, Isabelle, MD, MPH, DSc ; Staeger, Philippe, MD, MPH ; Bridevaux, Pierre-Olivier, MD, MSc ; Ghali, William A., MD, MPH ; Burnand, Bernard, MD, MPH</creatorcontrib><description>Abstract Background Disease-management programs may enhance the quality of care provided to patients with chronic diseases, such as chronic obstructive pulmonary disease (COPD). The aim of this systematic review was to assess the effectiveness of COPD disease-management programs. Methods We conducted a computerized search of MEDLINE, EMBASE, CINAHL, PsychINFO, and the Cochrane Library (CENTRAL) for studies evaluating interventions meeting our operational definition of disease management: patient education, 2 or more different intervention components, 2 or more health care professionals actively involved in patients' care, and intervention lasting 12 months or more. Programs conducted in hospital only and those targeting patients receiving palliative care were excluded. Two reviewers evaluated 12,749 titles and fully reviewed 139 articles; among these, data from 13 studies were included and extracted. Clinical outcomes considered were all-cause mortality, lung function, exercise capacity (walking distance), health-related quality of life, symptoms, COPD exacerbations, and health care use. A meta-analysis of exercise capacity and all-cause mortality was performed using random-effects models. Results The studies included were 9 randomized controlled trials, 1 controlled trial, and 3 uncontrolled before–after trials. Results indicate that the disease-management programs studied significantly improved exercise capacity (32.2 m, 95% confidence interval [CI], 4.1-60.3), decreased risk of hospitalization, and moderately improved health-related quality of life. All-cause mortality did not differ between groups (pooled odds ratio 0.84, 95% CI, 0.54-1.40). Conclusion COPD disease-management programs modestly improved exercise capacity, health-related quality of life, and hospital admissions, but not all-cause mortality. Future studies should explore the specific elements or characteristics of these programs that bring the greatest benefit.</description><identifier>ISSN: 0002-9343</identifier><identifier>EISSN: 1555-7162</identifier><identifier>DOI: 10.1016/j.amjmed.2008.02.009</identifier><identifier>PMID: 18456040</identifier><identifier>CODEN: AJMEAZ</identifier><language>eng</language><publisher>New York, NY: Elsevier Inc</publisher><subject>Ambulatory Care ; Biological and medical sciences ; Chronic obstructive pulmonary disease ; Disease Management ; Effectiveness ; General aspects ; Humans ; Internal Medicine ; Medical sciences ; Meta-analysis ; Miscellaneous ; Public health. Hygiene ; Public health. Hygiene-occupational medicine ; Pulmonary Disease, Chronic Obstructive - therapy ; Quality of care ; Systematic review</subject><ispartof>The American journal of medicine, 2008-05, Vol.121 (5), p.433-443.e4</ispartof><rights>Elsevier Inc.</rights><rights>2008 Elsevier Inc.</rights><rights>2008 INIST-CNRS</rights><rights>Copyright Elsevier Sequoia S.A. May 2008</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c472t-20f395d909117e76ef8827573c5b40256c93754909d3e14d6999e0dd9dae0a6d3</citedby><cites>FETCH-LOGICAL-c472t-20f395d909117e76ef8827573c5b40256c93754909d3e14d6999e0dd9dae0a6d3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0002934308001770$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=20532324$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/18456040$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Peytremann-Bridevaux, Isabelle, MD, MPH, DSc</creatorcontrib><creatorcontrib>Staeger, Philippe, MD, MPH</creatorcontrib><creatorcontrib>Bridevaux, Pierre-Olivier, MD, MSc</creatorcontrib><creatorcontrib>Ghali, William A., MD, MPH</creatorcontrib><creatorcontrib>Burnand, Bernard, MD, MPH</creatorcontrib><title>Effectiveness of Chronic Obstructive Pulmonary Disease-Management Programs: Systematic Review and Meta-Analysis</title><title>The American journal of medicine</title><addtitle>Am J Med</addtitle><description>Abstract Background Disease-management programs may enhance the quality of care provided to patients with chronic diseases, such as chronic obstructive pulmonary disease (COPD). The aim of this systematic review was to assess the effectiveness of COPD disease-management programs. Methods We conducted a computerized search of MEDLINE, EMBASE, CINAHL, PsychINFO, and the Cochrane Library (CENTRAL) for studies evaluating interventions meeting our operational definition of disease management: patient education, 2 or more different intervention components, 2 or more health care professionals actively involved in patients' care, and intervention lasting 12 months or more. Programs conducted in hospital only and those targeting patients receiving palliative care were excluded. Two reviewers evaluated 12,749 titles and fully reviewed 139 articles; among these, data from 13 studies were included and extracted. Clinical outcomes considered were all-cause mortality, lung function, exercise capacity (walking distance), health-related quality of life, symptoms, COPD exacerbations, and health care use. A meta-analysis of exercise capacity and all-cause mortality was performed using random-effects models. Results The studies included were 9 randomized controlled trials, 1 controlled trial, and 3 uncontrolled before–after trials. Results indicate that the disease-management programs studied significantly improved exercise capacity (32.2 m, 95% confidence interval [CI], 4.1-60.3), decreased risk of hospitalization, and moderately improved health-related quality of life. All-cause mortality did not differ between groups (pooled odds ratio 0.84, 95% CI, 0.54-1.40). Conclusion COPD disease-management programs modestly improved exercise capacity, health-related quality of life, and hospital admissions, but not all-cause mortality. Future studies should explore the specific elements or characteristics of these programs that bring the greatest benefit.</description><subject>Ambulatory Care</subject><subject>Biological and medical sciences</subject><subject>Chronic obstructive pulmonary disease</subject><subject>Disease Management</subject><subject>Effectiveness</subject><subject>General aspects</subject><subject>Humans</subject><subject>Internal Medicine</subject><subject>Medical sciences</subject><subject>Meta-analysis</subject><subject>Miscellaneous</subject><subject>Public health. Hygiene</subject><subject>Public health. Hygiene-occupational medicine</subject><subject>Pulmonary Disease, Chronic Obstructive - therapy</subject><subject>Quality of care</subject><subject>Systematic review</subject><issn>0002-9343</issn><issn>1555-7162</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2008</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkltv1DAQhSMEokvhHyAUIcFblvEtiXlAqpZykVq1ovBsee1JccileJKi_fc47Gof-oL8YFnzndH4nMmylwzWDFj5rl3bvu3RrzlAvQa-BtCPshVTShUVK_njbAUAvNBCipPsGVGbnqBV-TQ7YbVUJUhYZeN506Cbwj0OSJSPTb75GcchuPxqS1Oc_5Xy67nrx8HGXf4xEFrC4tIO9hZ7HKb8Oo630fb0Pr_Z0YS9nZL6G94H_JPbweeXONnibLDdjgI9z540tiN8cbhPsx-fzr9vvhQXV5-_bs4uCicrPhUcGqGV16AZq7AqsalrXqlKOLWVwFXptKiUTHUvkElfaq0RvNfeItjSi9Ps7b7vXRx_z0iT6QM57Do74DiTKTUraylFAl8_ANtxjmlaMlyko7SoEyT3kIsjUcTG3MXQJz8MA7OkYVqzT8MsaRjgJlmdZK8OveftUjuKDvYn4M0BsORs10Q7uEBHjoNaRpCJ-7DnMFmWjI2GXMDBoQ8xpWf8GP43ycMGrgspZdv9wh3S8cvMUBKYm2VzlsWBGoBVFYi_rQq-Yw</recordid><startdate>20080501</startdate><enddate>20080501</enddate><creator>Peytremann-Bridevaux, Isabelle, MD, MPH, DSc</creator><creator>Staeger, Philippe, MD, MPH</creator><creator>Bridevaux, Pierre-Olivier, MD, MSc</creator><creator>Ghali, William A., MD, MPH</creator><creator>Burnand, Bernard, MD, MPH</creator><general>Elsevier Inc</general><general>Elsevier</general><general>Elsevier Sequoia S.A</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>7TK</scope><scope>7TO</scope><scope>7TS</scope><scope>7U9</scope><scope>H94</scope><scope>K9.</scope><scope>7X8</scope></search><sort><creationdate>20080501</creationdate><title>Effectiveness of Chronic Obstructive Pulmonary Disease-Management Programs: Systematic Review and Meta-Analysis</title><author>Peytremann-Bridevaux, Isabelle, MD, MPH, DSc ; Staeger, Philippe, MD, MPH ; Bridevaux, Pierre-Olivier, MD, MSc ; Ghali, William A., MD, MPH ; Burnand, Bernard, MD, MPH</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c472t-20f395d909117e76ef8827573c5b40256c93754909d3e14d6999e0dd9dae0a6d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2008</creationdate><topic>Ambulatory Care</topic><topic>Biological and medical sciences</topic><topic>Chronic obstructive pulmonary disease</topic><topic>Disease Management</topic><topic>Effectiveness</topic><topic>General aspects</topic><topic>Humans</topic><topic>Internal Medicine</topic><topic>Medical sciences</topic><topic>Meta-analysis</topic><topic>Miscellaneous</topic><topic>Public health. Hygiene</topic><topic>Public health. Hygiene-occupational medicine</topic><topic>Pulmonary Disease, Chronic Obstructive - therapy</topic><topic>Quality of care</topic><topic>Systematic review</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Peytremann-Bridevaux, Isabelle, MD, MPH, DSc</creatorcontrib><creatorcontrib>Staeger, Philippe, MD, MPH</creatorcontrib><creatorcontrib>Bridevaux, Pierre-Olivier, MD, MSc</creatorcontrib><creatorcontrib>Ghali, William A., MD, MPH</creatorcontrib><creatorcontrib>Burnand, Bernard, MD, MPH</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Physical Education Index</collection><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><jtitle>The American journal of medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Peytremann-Bridevaux, Isabelle, MD, MPH, DSc</au><au>Staeger, Philippe, MD, MPH</au><au>Bridevaux, Pierre-Olivier, MD, MSc</au><au>Ghali, William A., MD, MPH</au><au>Burnand, Bernard, MD, MPH</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Effectiveness of Chronic Obstructive Pulmonary Disease-Management Programs: Systematic Review and Meta-Analysis</atitle><jtitle>The American journal of medicine</jtitle><addtitle>Am J Med</addtitle><date>2008-05-01</date><risdate>2008</risdate><volume>121</volume><issue>5</issue><spage>433</spage><epage>443.e4</epage><pages>433-443.e4</pages><issn>0002-9343</issn><eissn>1555-7162</eissn><coden>AJMEAZ</coden><abstract>Abstract Background Disease-management programs may enhance the quality of care provided to patients with chronic diseases, such as chronic obstructive pulmonary disease (COPD). The aim of this systematic review was to assess the effectiveness of COPD disease-management programs. Methods We conducted a computerized search of MEDLINE, EMBASE, CINAHL, PsychINFO, and the Cochrane Library (CENTRAL) for studies evaluating interventions meeting our operational definition of disease management: patient education, 2 or more different intervention components, 2 or more health care professionals actively involved in patients' care, and intervention lasting 12 months or more. Programs conducted in hospital only and those targeting patients receiving palliative care were excluded. Two reviewers evaluated 12,749 titles and fully reviewed 139 articles; among these, data from 13 studies were included and extracted. Clinical outcomes considered were all-cause mortality, lung function, exercise capacity (walking distance), health-related quality of life, symptoms, COPD exacerbations, and health care use. A meta-analysis of exercise capacity and all-cause mortality was performed using random-effects models. Results The studies included were 9 randomized controlled trials, 1 controlled trial, and 3 uncontrolled before–after trials. Results indicate that the disease-management programs studied significantly improved exercise capacity (32.2 m, 95% confidence interval [CI], 4.1-60.3), decreased risk of hospitalization, and moderately improved health-related quality of life. All-cause mortality did not differ between groups (pooled odds ratio 0.84, 95% CI, 0.54-1.40). Conclusion COPD disease-management programs modestly improved exercise capacity, health-related quality of life, and hospital admissions, but not all-cause mortality. Future studies should explore the specific elements or characteristics of these programs that bring the greatest benefit.</abstract><cop>New York, NY</cop><pub>Elsevier Inc</pub><pmid>18456040</pmid><doi>10.1016/j.amjmed.2008.02.009</doi><tpages>11</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0002-9343 |
ispartof | The American journal of medicine, 2008-05, Vol.121 (5), p.433-443.e4 |
issn | 0002-9343 1555-7162 |
language | eng |
recordid | cdi_proquest_miscellaneous_69168443 |
source | MEDLINE; Elsevier ScienceDirect Journals |
subjects | Ambulatory Care Biological and medical sciences Chronic obstructive pulmonary disease Disease Management Effectiveness General aspects Humans Internal Medicine Medical sciences Meta-analysis Miscellaneous Public health. Hygiene Public health. Hygiene-occupational medicine Pulmonary Disease, Chronic Obstructive - therapy Quality of care Systematic review |
title | Effectiveness of Chronic Obstructive Pulmonary Disease-Management Programs: Systematic Review and Meta-Analysis |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-05T02%3A41%3A25IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Effectiveness%20of%20Chronic%20Obstructive%20Pulmonary%20Disease-Management%20Programs:%20Systematic%20Review%20and%20Meta-Analysis&rft.jtitle=The%20American%20journal%20of%20medicine&rft.au=Peytremann-Bridevaux,%20Isabelle,%20MD,%20MPH,%20DSc&rft.date=2008-05-01&rft.volume=121&rft.issue=5&rft.spage=433&rft.epage=443.e4&rft.pages=433-443.e4&rft.issn=0002-9343&rft.eissn=1555-7162&rft.coden=AJMEAZ&rft_id=info:doi/10.1016/j.amjmed.2008.02.009&rft_dat=%3Cproquest_cross%3E1507559891%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=232325938&rft_id=info:pmid/18456040&rft_els_id=1_s2_0_S0002934308001770&rfr_iscdi=true |